A natural substance isolated from a houseplant shows promise as a potential treatment to prevent and reverse pulmonary hypertension…
Articles by Patricia Inácio, PhD
Reviva Pharmaceuticals has been granted a patent in Europe that covers using brilaroxazine, formerly RP5063, for pulmonary hypertension…
Anumana‘s artificial intelligence (AI) algorithm shows promise for the early detection of pulmonary hypertension (PH), a study suggested.
A new study identifies the presence of bacteria from the genus Eubacterium fissicatena, known for their pro-inflammatory properties, as a…
The physical activity component of the PAH-SYMPACT — a patient-reported measure of quality of life tailored for people with…
Direct oral anticoagulants (DOACs) — a type of blood thinner medication — are as safe and effective as vitamin K…
Life support measures, specifically the need for assisted breathing, and elevated blood levels of bilirubin, a marker of liver damage,…
Tenax Therapeutics has been granted another U.S. patent for levosimendan, this one covering all three routes of administration and…
Elevated levels of two tumor biomarkers, AFP and CA125, were found to predict disease worsening in people with idiopathic…
About 41% of pulmonary arterial hypertension (PAH) patients in a multinational survey were initially misdiagnosed, seeing an average of…
An algorithm based on artificial intelligence (AI) and machine learning may help in diagnosing pulmonary hypertension (PH), a new…
Aria CV’s second-generation medical device for treating people with pulmonary arterial hypertension (PAH) — a balloon system…